BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mortoglou M, Tabin ZK, Arisan ED, Kocher HM, Uysal-Onganer P. Non-coding RNAs in pancreatic ductal adenocarcinoma: New approaches for better diagnosis and therapy. Transl Oncol 2021;14:101090. [PMID: 33831655 DOI: 10.1016/j.tranon.2021.101090] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Wang ZH, Ye LL, Xiang X, Wei XS, Niu YR, Peng WB, Zhang SY, Zhang P, Xue QQ, Wang HL, Du YH, Liu Y, Ai JQ, Zhou Q. Circular RNA circFBXO7 attenuates non-small cell lung cancer tumorigenesis by sponging miR-296-3p to facilitate KLF15-mediated transcriptional activation of CDKN1A. Transl Oncol 2023;30:101635. [PMID: 36774884 DOI: 10.1016/j.tranon.2023.101635] [Reference Citation Analysis]
2 Pandey S, Gupta VK, Lavania SP. Role of epigenetics in pancreatic ductal adenocarcinoma. Epigenomics 2023. [PMID: 36647796 DOI: 10.2217/epi-2022-0177] [Reference Citation Analysis]
3 Donati S, Aurilia C, Palmini G, Falsetti I, Iantomasi T, Brandi ML. Autophagy-Related ncRNAs in Pancreatic Cancer. Pharmaceuticals (Basel) 2022;15. [PMID: 36558998 DOI: 10.3390/ph15121547] [Reference Citation Analysis]
4 Bravo-Vázquez LA, Frías-Reid N, Ramos-Delgado AG, Osorio-Pérez SM, Zlotnik-Chávez HR, Pathak S, Banerjee A, Bandyopadhyay A, Duttaroy AK, Paul S. MicroRNAs and long non-coding RNAs in pancreatic cancer: From epigenetics to potential clinical applications. Transl Oncol 2022;27:101579. [PMID: 36332600 DOI: 10.1016/j.tranon.2022.101579] [Reference Citation Analysis]
5 Mortoglou M, Manić L, Buha Djordjevic A, Bulat Z, Đorđević V, Manis K, Valle E, York L, Wallace D, Uysal-Onganer P. Nickel's Role in Pancreatic Ductal Adenocarcinoma: Potential Involvement of microRNAs. Toxics 2022;10:148. [PMID: 35324773 DOI: 10.3390/toxics10030148] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Zheng S, Hu C, Lin H, Li G, Xia R, Zhang X, Su D, Li Z, Zhou Q, Chen R. circCUL2 induces an inflammatory CAF phenotype in pancreatic ductal adenocarcinoma via the activation of the MyD88-dependent NF-κB signaling pathway. J Exp Clin Cancer Res 2022;41. [DOI: 10.1186/s13046-021-02237-6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Sikdar N, Bararia A, Dutta A, Banerjee S. Long Noncoding RNA Acting as Therapeutic Target for Oxidative Stress-Induced Pancreatic Cancer. Handbook of Oxidative Stress in Cancer: Therapeutic Aspects 2022. [DOI: 10.1007/978-981-16-5422-0_77] [Reference Citation Analysis]
8 Burenina OY, Lazarevich NL, Kustova IF, Zatsepin TS, Rubtsova MP, Dontsova OA. Expression of CASC8 RNA in Human Pancreatic Cancer Cell Lines. Dokl Biochem Biophys 2022;505:137-40. [PMID: 36038677 DOI: 10.1134/S1607672922040020] [Reference Citation Analysis]
9 Sikdar N, Bararia A, Dutta A, Banerjee S. Long Noncoding RNA Acting as Therapeutic Target for Oxidative Stress-Induced Pancreatic Cancer. Handbook of Oxidative Stress in Cancer: Therapeutic Aspects 2022. [DOI: 10.1007/978-981-16-1247-3_77-1] [Reference Citation Analysis]
10 Mortoglou M, Buha Djordjevic A, Djordjevic V, Collins H, York L, Mani K, Valle E, Wallace D, Uysal-Onganer P. Role of microRNAs in response to cadmium chloride in pancreatic ductal adenocarcinoma. Arch Toxicol 2021. [PMID: 34905088 DOI: 10.1007/s00204-021-03196-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
11 Xiong G, Pan S, Jin J, Wang X, He R, Peng F, Li X, Wang M, Zheng J, Zhu F, Qin R. Long Noncoding Competing Endogenous RNA Networks in Pancreatic Cancer. Front Oncol 2021;11:765216. [PMID: 34760707 DOI: 10.3389/fonc.2021.765216] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
12 Honoré N, Galot R, van Marcke C, Limaye N, Machiels JP. Liquid Biopsy to Detect Minimal Residual Disease: Methodology and Impact. Cancers (Basel) 2021;13:5364. [PMID: 34771526 DOI: 10.3390/cancers13215364] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
13 Khakoo S, Petrillo A, Salati M, Muhith A, Evangelista J, Seghezzi S, Petrelli F, Tomasello G, Ghidini M. Neoadjuvant Treatment for Pancreatic Adenocarcinoma: A False Promise or an Opportunity to Improve Outcome? Cancers (Basel) 2021;13:4396. [PMID: 34503206 DOI: 10.3390/cancers13174396] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
14 Li Y, Al Hallak MN, Philip PA, Azmi AS, Mohammad RM. Non-Coding RNAs in Pancreatic Cancer Diagnostics and Therapy: Focus on lncRNAs, circRNAs, and piRNAs. Cancers (Basel) 2021;13:4161. [PMID: 34439315 DOI: 10.3390/cancers13164161] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]